Notice of Special Interest (NOSI) Hearing Healthcare for Adults: Improving Access and Affordability
Kelly King, Au.D, Ph.D.
Peer review contact:
Peer review contact information will appear in the applicant's eRA Commons account approximately 2 weeks after the submission date.
Financial and grants management
This opportunity is a Notice of Special Interest (NOSI) for research to improve access and affordability of hearing healthcare (HHC) in adults.
A detailed list of research objectives is provided on the program website.
Objectives of interest to rural areas may include:
- Conduct research addressing rural health issues potentially affecting HHC utilization and the unique HHC needs of rural populations
- Evaluate innovative models including, but not limited to, community health workers, telehealth, mobile health, retail clinics, and self-administered hearing healthcare, with outcomes that are patient centered
- Conduct studies seeking to improve understanding of HHC disparities and to investigate how economic, racial, cultural, gender, and age-related factors may influence HHC use and patient-centered outcomes
Eligible applicants include:
- Higher education institutions
- Public/state controlled institutions
- Private institutions
- Nonprofit organizations
- With 501(c)(3) status
- Without 501(c)(3) status
- Native American tribal organizations
- Faith-based or community-based organizations
- Regional organizations
- City or township
- Special districts
- Federally recognized Indian/Native American tribal governments
- Indian/Native American tribal governments (other than federally recognized)
- Eligible agencies of the federal government
- U.S. territory or possession
- Independent school districts
- Public housing authorities
- Indian housing authorities
- Small businesses
- For-profit organizations
Funding amounts vary based on the parent funding announcement.
This is a NOSI that is attached to related NIH announcements:
- NIDCD Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
- NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 – Clinical Trial Required)
- PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
- PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
- PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
Applicants should submit proposals to the related announcement and indicate that it is a response to the NOSI. The NOSI applies to due dates on or after June 5, 2021 and subsequent receipt dates through January 7, 2024.
For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.